We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Boston University and Fraunhofer Create Alliance

By Labmedica staff writers
Posted on 30 Nov 2006
Boston University (BU, Boston, MA, USA) and its College of Engineering are joining Fraunhofer Gesellschaft (Munich, Germany) to create the Boston University-Fraunhofer Alliance for Medical Devices, Instrumentation and Diagnostics. More...
BU and Fraunhofer will jointly fund the five-year, U.S.$5 million alliance, which aims to develop arrays for diagnostic applications.

Andrew Sharon, a BU engineering professor and director of the Fraunhofer Center for Manufacturing and Innovation, said that the alliance will create disposable chips for molecular-level disease diagnosis. The firm will fabricate DNA and peptide arrays and perform translational research with the medical school. An optically guided colon-cancer detection and treatment system is a promising innovation also under consideration for initial support by the alliance.

The alliance seeks to take advantage of the two institutions' respective strengths. Advanced biomedical engineering research being conducted throughout BU's College of Engineering, College of Arts and Sciences, and Medical School, generally proceeds to the laboratory bench level. Fraunhofer hopes to take these innovations and convert them into working medical devices and instruments that can be licensed to existing companies or new, spin-off ventures.

Fraunhofer Gesellschaft is very active in biomedical research. Current activities include array-based diagnostics, medical imaging, surgical micro-tools development, and other novel devices and instrumentation. The Fraunhofer Center for Manufacturing Innovation was established at Boston University in 1994. The center scales up basic research into advanced industrial technologies that meet the needs of client companies both locally and globally.



Related Links:
Boston University
Fraunhofer Gesellschaft

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.